Rockefeller Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Rockefeller Capital Management’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$845K	Buy	10,667 +1	+0%	+$81	﹤0.01%	1692
2025 Q4	$876K	Buy	10,666 +666	+7%	+$51.5K	﹤0.01%	1609
2025 Q3	$699K	Hold	10,000	–	–	﹤0.01%	1609
2025 Q2	$641K	Hold	10,000	–	–	﹤0.01%	1480
2025 Q1	$634K	Sell	10,000 -19	-0.2%	-$1.28K	﹤0.01%	1408
2024 Q4	$667K	Hold	10,019	–	–	﹤0.01%	1386
2024 Q3	$700K	Hold	10,019	–	–	﹤0.01%	1342
2024 Q2	$649K	Hold	10,019	–	–	﹤0.01%	1359
2024 Q1	$648K	Sell	10,019 -41	-0.4%	-$2.67K	﹤0.01%	1392
2023 Q4	$662K	Buy	10,060 +60	+0.6%	+$3.49K	﹤0.01%	1270
2023 Q3	$570K	Hold	10,000	–	–	﹤0.01%	1254
2023 Q2	$613K	Hold	10,000	–	–	﹤0.01%	1262
2023 Q1	$627K	Hold	10,000	–	–	﹤0.01%	1246
2022 Q4	$634K	Hold	10,000	–	–	﹤0.01%	1185
2022 Q3	$589K	Hold	10,000	–	–	﹤0.01%	1208
2022 Q2	$577K	Hold	10,000	–	–	﹤0.01%	1203
2022 Q1	$620K	Hold	10,000	–	–	﹤0.01%	1235
2021 Q4	$712K	Hold	10,000	–	–	﹤0.01%	1182
2021 Q3	$748K	Hold	10,000	–	–	﹤0.01%	1103
2021 Q2	$773K	Hold	10,000	–	–	﹤0.01%	1025
2021 Q1	$738K	Hold	10,000	–	–	0.01%	888
2020 Q4	$701K	Buy	+10,000	New	+$633K	0.01%	803

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Rockefeller Capital Management's PBE Position: Q1 2026 in Review

Rockefeller Capital Management increased its Invesco Biotechnology & Genome ETF (PBE) stake by 0.01% in Q1 2026, buying an estimated $81 and bringing the position to 10,667 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Rockefeller Capital Management first reported a position in PBE in Q4 2020 and has held it in 22 quarters since. The position peaked at $876K in Q4 2025. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

Rockefeller Capital Management held 10,667 shares of Invesco Biotechnology & Genome ETF worth $845K as of Q1 2026.
Rockefeller Capital Management bought 1 Invesco Biotechnology & Genome ETF share in Q1 2026, an estimated $81.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1692 holding.
Rockefeller Capital Management first reported a position in Invesco Biotechnology & Genome ETF in Q4 2020 and has held it in 22 quarters since.
Rockefeller Capital Management's Invesco Biotechnology & Genome ETF position peaked at $876K in Q4 2025.
100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.